Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
EVIDENCE FOR 2 DIFFERENT IMIDAZOLINE SITES ON PANCREATIC B-CELLS AND VASCULAR BED IN RAT
Autore:
BERDEU D; GROSS R; PUECH R; LOUBATIERESMARIANI MM; BERTRAND G;
Indirizzi:
FAC MED MONTPELLIER,INST BIOL,PHARMACOL LAB,BLVD HENRI IV F-34060 MONTPELLIER FRANCE FAC MED MONTPELLIER,INST BIOL,PHARMACOL LAB F-34060 MONTPELLIER FRANCE CNRS,INSERM,CTR PHARMACOL ENDOCRINOL,UPR 9023 F-34094 MONTPELLIER FRANCE CNRS,UMR 9921 MONTPELLIER FRANCE
Titolo Testata:
European journal of pharmacology
fascicolo: 1, volume: 275, anno: 1995,
pagine: 91 - 98
SICI:
0014-2999(1995)275:1<91:EF2DIS>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
SENSITIVE K+ CHANNELS; ALPHA-ADRENOCEPTOR ANTAGONISTS; IDAZOXAN-BINDING-SITES; INSULIN-SECRETION; NORADRENALINE RELEASE; POTASSIUM CHANNELS; CEREBRAL-CORTEX; H-3 IDAZOXAN; BETA-CELLS; RECEPTORS;
Keywords:
IMIDAZOLINE; IMIDAZOLINE SITE; INSULIN SECRETION; VESSEL; PANCREAS; EFAROXAN; IDAZOXAN; (RAT);
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
44
Recensione:
Indirizzi per estratti:
Citazione:
D. Berdeu et al., "EVIDENCE FOR 2 DIFFERENT IMIDAZOLINE SITES ON PANCREATIC B-CELLS AND VASCULAR BED IN RAT", European journal of pharmacology, 275(1), 1995, pp. 91-98

Abstract

The relative potencies of imidazoline compounds to induce insulin secretion and vascular resistance were compared in the isolated perfused rat pancreas. On insulin secretion, only the two imidazolines, antazoline and efaroxan, induced a concentration-dependent response, antazoline being 10 times more potent than efaroxan. In contrast, idazoxan, a blocker of imidazoline I-1 sites, at concentrations up to 30 mu M, antagonized the insulin response to 10 mu M efaroxan (IC50 congruent to 14 +/- 2 mu M) without affecting that to 3 mu M tolbutamide. On pancreatic vessels, not only antazoline and efaroxan but also idazoxan induced a concentration-dependent vasoconstriction; the rank order of agonist potency was antazoline > efaroxan > idazoxan. In addition, cimetidine, an imidazole known to bind imidazoline I-1 sites, ineffective per se, partially reversed the insulin stimulatory effect of efaroxan without affecting its vasoconstrictor effect. This study demonstrates that the insulin secretory and vasoconstrictor actions of imidazolines involve different imidazoline sites in rat pancreas. The results provide evidence for an I-1 type mediating insulin secretion on B cells and an I-1 type mediating vasoconstriction in vessels.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/07/20 alle ore 08:07:35